WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 1 to 25 of about 5078

Website Changes

10/29/2020

Alpha-type-1 Polarized Dendritic Cell-based Vaccination in Newly Diagnosed High-grade Glioma: A Phase II Clinical Trial

10/26/2020

Evolution of radiotherapies for brain tumors - the story of GammaTile Therapy.

10/19/2020

Midatech Pharma PLC Announces Headline Results of MTX110 Phase I DIPG Study

10/15/2020

Musella Foundation Copayment Assistance Program Closed to New patients

10/08/2020

What would YOU do if you were diagnosed with GBM?

10/04/2020

Musella Foundation Copay Assistance Program Status

10/04/2020

Brain TUmor Webinar Tonight!

09/29/2020

Musella Foundation Copay Assistance Program is now open!

09/28/2020

xCures announces the launch of a Compassionate Use program for ulixertinib (BVD-523)

09/18/2020

Treatment Outcomes of Persistent Radiation-Induced Alopecia in Patients With Cancer

09/17/2020

Cs-131 brachytherapy for patients with recurrent glioblastoma combined with bevacizumab avoids radiation necrosis while maintaining local control

09/14/2020

2nd Annual Brain Tumor TOGETHER and ACTION Day

09/11/2020

Medexus gets Health Canada nod to market tumor imaging material Gleolan for neurosurgery

09/09/2020

New Webinar Added: Assessment of Treatment Response to Established and Novel Therapies in Glioblastoma Patients using Metabolic and Physiologic MR Imaging Techniques

09/02/2020

Return to work following diagnosis of low-grade glioma

08/31/2020

Glioblastoma Utilizes Fatty Acids and Ketone Bodies for Growth Allowing Progression during Ketogenic Diet Therapy

08/29/2020

Prevention and Management of Dermatologic Adverse Events Associated With Tumor Treating Fields in Patients With Glioblastoma

08/25/2020

GT Medical Technologies Announces Data Demonstrating Positive Local Control and Safety Outcomes with GammaTile Therapy for Large Brain Metastases

08/24/2020

Phase I trial of convection-enhanced delivery of IL13RA2 and EPHA2 receptor targeted cytotoxins in dogs with spontaneous intracranial gliomas

08/24/2020

The dopamine receptor antagonist trifluoperazine prevents phenotype conversion and improves survival in mouse models of glioblastoma

08/24/2020

A phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high-grade glioma

08/24/2020

Prognostic Value of ABO Blood Groups in Patients with Glioblastoma Multiforme

08/23/2020

Ketone-Supressing Drug Combats Rare Brain Cancer in Mice

08/23/2020

Northwell neurosurgeon first on Long Island to use Modus V™ 3D exoscope to remove brain tumor

08/23/2020

ERC Announces Interim Results from Phase 2 Trial of Immunotherapy ERC1671 (Gliovac) in Recurrent Glioblastoma Patients